{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:15:31Z","timestamp":1780377331201,"version":"3.54.1"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10620-024-08597-1","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:33:08Z","timestamp":1727299988000},"page":"4187-4202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Risk Factors for Gallstones in Crohn\u2019s Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"69","author":[{"given":"Yan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"8597_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","volume":"12","author":"AN Ananthakrishnan","year":"2015","unstructured":"Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12:205\u2013217.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"8597_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","volume":"18","author":"K Gg","year":"2021","unstructured":"Gg K, Jw W. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2021;18:56\u201366.","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"8597_CR3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3349\/ymj.2021.62.2.99","volume":"62","author":"J Park","year":"2021","unstructured":"Park J, Cheon JH. Incidence and prevalence of inflammatory bowel disease across Asia. Yonsei Med J. 2021;62:99\u2013108.","journal-title":"Yonsei Med J."},{"key":"8597_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","volume":"40","author":"E Gizard","year":"2014","unstructured":"Gizard E, Ford AC, Bronowicki J-P et al. Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2014;40:3\u201315.","journal-title":"Aliment Pharmacol Ther."},{"key":"8597_CR5","first-page":"e26121","volume":"14","author":"MMA Baig","year":"2022","unstructured":"Baig MMA, Irfan SA, Sumbal A et al. Prevalence of gallstones in ulcerative colitis and Crohn\u2019s disease: a systematic review and meta-analysis. Cureus. 2022;14:e26121.","journal-title":"Cureus."},{"key":"8597_CR6","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10620-021-06899-2","volume":"67","author":"ML Montenegro","year":"2022","unstructured":"Montenegro ML, Corral JE, Lukens FJ et al. Pancreatic disorders in patients with inflammatory bowel disease. Dig Dis Sci. 2022;67:423\u2013436. https:\/\/doi.org\/10.1007\/s10620-021-06899-2","journal-title":"Dig Dis Sci."},{"key":"8597_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MOG.0000000000000418","volume":"34","author":"DM Shabanzadeh","year":"2018","unstructured":"Shabanzadeh DM. Incidence of gallstone disease and complications. Curr Opin Gastroenterol. 2018;34:81\u201389.","journal-title":"Curr Opin Gastroenterol."},{"key":"8597_CR8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00004836-200305000-00012","volume":"36","author":"S Bargiggia","year":"2003","unstructured":"Bargiggia S, Maconi G, Elli M et al. Sonographic prevalence of liver steatosis and biliary tract stones in patients with inflammatory bowel disease: study of 511 subjects at a single center. J Clin Gastroenterol. 2003;36:417\u2013420.","journal-title":"J Clin Gastroenterol."},{"key":"8597_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185193","volume":"12","author":"S Fagagnini","year":"2017","unstructured":"Fagagnini S, Heinrich H, Rossel J-B et al. Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases. PLoS One. 2017;12:e0185193.","journal-title":"PLoS One."},{"key":"8597_CR10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1572-0241.1999.01076.x","volume":"94","author":"A Lapidus","year":"1999","unstructured":"Lapidus A, B\u00e5ngstad M, Astr\u00f6m M et al. The prevalence of gallstone disease in a defined cohort of patients with Crohn\u2019s disease. Am J Gastroenterol. 1999;94:1261\u20131266.","journal-title":"Am J Gastroenterol."},{"key":"8597_CR11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.crohns.2012.02.002","volume":"6","author":"J Lin","year":"2012","unstructured":"Lin J, Shen B, Lee H-J et al. Histopathological characterization of cholecystectomy specimens in patients with inflammatory bowel disease. J Crohns Colitis. 2012;6:895\u2013899.","journal-title":"J Crohns Colitis."},{"key":"8597_CR12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/MPG.0000000000001492","volume":"64","author":"LJ Saubermann","year":"2017","unstructured":"Saubermann LJ, Deneau M, Falcone RA et al. Hepatic issues and complications associated with inflammatory bowel disease: a clinical report from the naspghan inflammatory bowel disease and hepatology committees. J Pediatr Gastroenterol Nutr. 2017;64:639\u2013652.","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"8597_CR13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12876-019-0967-3","volume":"19","author":"FS Fousekis","year":"2019","unstructured":"Fousekis FS, Katsanos KH, Theopistos VI et al. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study. BMC Gastroenterol. 2019;19:48.","journal-title":"BMC Gastroenterol."},{"key":"8597_CR14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/00015458.2001.12098580","volume":"101","author":"M La Meir","year":"2001","unstructured":"La Meir M, Van Molhem Y. Recurrence of gallstone ileus with Crohn\u2019s disease. Acta Chir Belg. 2001;101:35\u201337.","journal-title":"Acta Chir Belg."},{"key":"8597_CR15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ibd\/izaa076","volume":"27","author":"F Koutroumpakis","year":"2021","unstructured":"Koutroumpakis F, Lodhi M, Ahsan M et al. The impact of cholecystectomy on long-term disease outcomes and quality of life in patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2021;27:336\u2013343.","journal-title":"Inflamm Bowel Dis."},{"key":"8597_CR16","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s10350-004-6798-4","volume":"46","author":"SSB Chew","year":"2003","unstructured":"Chew SSB, Ngo TQ, Douglas PR et al. Cholecystectomy in patients with Crohn\u2019s ileitis. Dis Colon Rectum. 2003;46:1484\u20131488.","journal-title":"Dis Colon Rectum."},{"key":"8597_CR17","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1007\/s11605-018-4028-y","volume":"23","author":"JC Goet","year":"2019","unstructured":"Goet JC, Beelen EMJ, Biermann KE et al. Cholecystectomy risk in Crohn\u2019s disease patients after ileal resection: a long-term nationwide cohort study. J Gastrointest Surg. 2019;23:1840\u20131847.","journal-title":"J Gastrointest Surg."},{"key":"8597_CR18","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1001\/archinte.161.18.2201","volume":"161","author":"M Fraquelli","year":"2001","unstructured":"Fraquelli M, Losco A, Visentin S et al. Gallstone disease and related risk factors in patients with Crohn disease: analysis of 330 consecutive cases. Arch Intern Med. 2001;161:2201\u20132204.","journal-title":"Arch Intern Med."},{"key":"8597_CR19","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.3748\/wjg.v11.i39.6170","volume":"11","author":"W Kratzer","year":"2005","unstructured":"Kratzer W, Haenle M-M, Mason R-A et al. Prevalence of cholelithiasis in patients with chronic inflammatory bowel disease. World J Gastroenterol. 2005;11:6170\u20136175.","journal-title":"World J Gastroenterol."},{"key":"8597_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.meg.0000243883.47938.aa","volume":"19","author":"MB Acosta","year":"2007","unstructured":"Acosta MB, Dominguez-Munoz JE, de Nunez-Pardo Vera MC et al. Relationship between clinical features of Crohn\u2019s disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol. 2007;19:73\u201378.","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"8597_CR21","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.33549\/physiolres.934302","volume":"68","author":"I Sturdik","year":"2019","unstructured":"Sturdik I, Krajcovicova A, Jalali Y et al. Pathophysiology and risk factors for cholelithiasis in patients with Crohn\u2019s disease. Physiol Res. 2019;68:S173\u2013S182.","journal-title":"Physiol Res."},{"key":"8597_CR22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/gut.35.1.94","volume":"35","author":"R Hutchinson","year":"1994","unstructured":"Hutchinson R, Tyrrell PN, Kumar D et al. Pathogenesis of gall stones in Crohn\u2019s disease: an alternative explanation. Gut. 1994;35:94\u201397.","journal-title":"Gut."},{"key":"8597_CR23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","volume":"14","author":"CK-L Lo","year":"2014","unstructured":"Lo CK-L, Mertz D, Loeb M. Newcastle\u2013Ottawa scale: comparing reviewers\u2019 to authors\u2019 assessments. BMC Med Res Methodol. 2014;14:45.","journal-title":"BMC Med Res Methodol."},{"key":"8597_CR24","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JAC Sterne","year":"2011","unstructured":"Sterne JAC, Sutton AJ, Ioannidis JPA et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.","journal-title":"BMJ."},{"key":"8597_CR25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u2013560.","journal-title":"BMJ."},{"key":"8597_CR26","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.21537","volume":"45","author":"F Parente","year":"2007","unstructured":"Parente F, Pastore L, Bargiggia S et al. Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study. Hepatology. 2007;45:1267\u20131274.","journal-title":"Hepatology."},{"key":"8597_CR27","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4321\/S1130-01082006000700004","volume":"98","author":"A Repiso","year":"2006","unstructured":"Repiso A, Alc\u00e1ntara M, Mu\u00f1oz-Rosas C et al. Extraintestinal manifestations of Crohn\u2019s disease: prevalence and related factors. Rev Esp Enferm Dig. 2006;98:510\u2013517.","journal-title":"Rev Esp Enferm Dig."},{"key":"8597_CR28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/BF02052328","volume":"33","author":"D Lorusso","year":"1990","unstructured":"Lorusso D, Leo S, Mossa A et al. Cholelithiasis in inflammatory bowel disease: a case\u2013control study. Dis Colon Rectum. 1990;33:791\u2013794.","journal-title":"Dis Colon Rectum."},{"key":"8597_CR29","first-page":"7604939","volume":"2019","author":"J Silva","year":"2019","unstructured":"Silva J, Brito BS, de Silva INN et al. Frequency of hepatobiliary manifestations and concomitant liver disease in inflammatory bowel disease patients. Biomed Res Int. 2019;2019:7604939.","journal-title":"Biomed Res Int."},{"key":"8597_CR30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/1751-2980.12286","volume":"16","author":"FM Zhang","year":"2015","unstructured":"Zhang FM, Xu CF, Shan GD et al. Is gallstone disease associated with inflammatory bowel diseases? A meta-analysis. J Dig Dis. 2015;16:634\u2013641.","journal-title":"J Dig Dis."},{"key":"8597_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ijo.2013.83","volume":"38","author":"K Johansson","year":"2014","unstructured":"Johansson K, Sundstr\u00f6m J, Marcus C et al. Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study. Int J Obes. 2014;38:279\u2013284.","journal-title":"Int J Obes."},{"key":"8597_CR32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","volume":"6","author":"LM Stinton","year":"2012","unstructured":"Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012;6:172\u2013187.","journal-title":"Gut Liver."},{"key":"8597_CR33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1017\/S000711451900028X","volume":"121","author":"H-Y Hsu","year":"2019","unstructured":"Hsu H-Y, Huang C-Y, Hwang L-C. Sex difference of the predictive value of BMI, waist circumference and percentage body fat mass for gallstone disease. Br J Nutr. 2019;121:955\u2013960.","journal-title":"Br J Nutr."},{"key":"8597_CR34","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/17474124.2023.2242784","volume":"17","author":"N Wen","year":"2023","unstructured":"Wen N, Wang Y, Cai Y, Nie G et al. Risk factors for recurrent common bile duct stones: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2023;17:937\u2013947.","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"8597_CR35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/1751-2980.12857","volume":"21","author":"ST Song","year":"2020","unstructured":"Song ST, Shi J, Wang XH et al. Prevalence and risk factors for gallstone disease: a population-based cross-sectional study. J Dig Dis. 2020;21:237\u2013245.","journal-title":"J Dig Dis."},{"key":"8597_CR36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000517270","volume":"40","author":"HS Colvin","year":"2022","unstructured":"Colvin HS, Kimura T, Iso H et al. Risk factors for gallstones and cholecystectomy: a large-scale population-based prospective cohort study in Japan. Dig Dis. 2022;40:385\u2013393.","journal-title":"Dig Dis."},{"key":"8597_CR37","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1159\/000201483","volume":"58","author":"AOMC Dami\u00e3o","year":"1997","unstructured":"Dami\u00e3o AOMC, Sipahi AM, Vezozzo DP et al. Gallbladder hypokinesia in Crohn\u2019s disease. Digestion. 1997;58:458\u2013463.","journal-title":"Digestion."},{"key":"8597_CR38","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/003655200750056628","volume":"35","author":"MK Vu","year":"2000","unstructured":"Vu MK, Gielkens HA, van Hogezand RA et al. Gallbladder motility in Crohn disease: influence of disease localization and bowel resection. Scand J Gastroenterol. 2000;35:1157\u20131162.","journal-title":"Scand J Gastroenterol."},{"key":"8597_CR39","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S1590-8658(03)00092-6","volume":"35","author":"AAM Masclee","year":"2003","unstructured":"Masclee AAM, Vu MK. Gallbladder motility in inflammatory bowel diseases. Dig Liver Dis. 2003;35:S35\u2013S38.","journal-title":"Dig Liver Dis."},{"key":"8597_CR40","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0016-5085(99)70507-X","volume":"116","author":"MA Brink","year":"1999","unstructured":"Brink MA, Slors JF, Keulemans YC et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn\u2019s disease. Gastroenterology. 1999;116:1420\u20131427.","journal-title":"Gastroenterology."},{"key":"8597_CR41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1365-2362.2003.01214.x","volume":"33","author":"L V\u00edtek","year":"2003","unstructured":"V\u00edtek L, Carey MC. Enterohepatic cycling of bilirubin as a cause of \u2018black\u2019 pigment gallstones in adult life. Eur J Clin Invest. 2003;33:799\u2013810.","journal-title":"Eur J Clin Invest."},{"key":"8597_CR42","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1046\/j.1365-2036.2003.01529.x","volume":"17","author":"SP Pereira","year":"2003","unstructured":"Pereira SP, Bain IM, Kumar D et al. Bile composition in inflammatory bowel disease: ileal disease and colectomy, but not colitis, induce lithogenic bile. Aliment Pharmacol Ther. 2003;17:923\u2013933.","journal-title":"Aliment Pharmacol Ther."},{"key":"8597_CR43","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1053\/gast.1996.v110.pm8964422","volume":"110","author":"M Brink","year":"1996","unstructured":"Brink M, MendezSanchez N, Carey M. Bilirubin cycles enterohepatically after ileal resection in the rat. Gastroenterology. 1996;110:1945\u20131957.","journal-title":"Gastroenterology."},{"key":"8597_CR44","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3748\/wjg.v12.i1.70","volume":"12","author":"A Lapidus","year":"2006","unstructured":"Lapidus A, Akerlund J-E, Einarsson C. Gallbladder bile composition in patients with Crohn \u2018s disease. World J Gastroenterol. 2006;12:70\u201374.","journal-title":"World J Gastroenterol."},{"key":"8597_CR45","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/gut.13.6.415","volume":"13","author":"RH Dowling","year":"1972","unstructured":"Dowling RH, Bell GD, White J. Lithogenic bile in patients with ileal dysfunction. Gut. 1972;13:415\u2013420.","journal-title":"Gut."},{"key":"8597_CR46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0168-8278(99)80349-3","volume":"31","author":"YCA Keulemans","year":"1999","unstructured":"Keulemans YCA, Mok KS, Slors JFM et al. Concanavalin A-binding cholesterol crystallization inhibiting and promoting activity in bile from patients with Crohn\u2019s disease compared to patients with ulcerative colitis. J Hepatol. 1999;31:685\u2013691.","journal-title":"J Hepatol."},{"key":"8597_CR47","first-page":"807","volume":"43","author":"P Maurer","year":"1996","unstructured":"Maurer P, Haag K, Roth M et al. No evidence for abnormal gallbladder emptying in Crohn\u2019s disease. Hepatogastroenterology. 1996;43:807\u2013812.","journal-title":"Hepatogastroenterology."},{"key":"8597_CR48","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3748\/wjg.15.1886","volume":"15","author":"H Sun","year":"2009","unstructured":"Sun H, Tang H, Jiang S et al. Gender and metabolic differences of gallstone diseases. World J Gastroenterol. 2009;15:1886\u20131891.","journal-title":"World J Gastroenterol."},{"key":"8597_CR49","first-page":"2304","volume":"21","author":"PL Pringle","year":"2015","unstructured":"Pringle PL, Stewart KO, Peloquin JM et al. Body mass index, genetic susceptibility, and risk of complications among individuals with Crohn\u2019s disease. Inflamm Bowel Dis. 2015;21:2304\u20132310.","journal-title":"Inflamm Bowel Dis."},{"key":"8597_CR50","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.crohns.2012.09.009","volume":"7","author":"T Nic Suibhne","year":"2013","unstructured":"Nic Suibhne T, Raftery TC, McMahon O et al. High prevalence of overweight and obesity in adults with Crohn\u2019s disease: associations with disease and lifestyle factors. J Crohn\u2019s Colitis. 2013;7:e241\u2013e248.","journal-title":"J Crohn\u2019s Colitis."},{"key":"8597_CR51","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.3748\/wjg.v29.i12.1779","volume":"29","author":"JH Kim","year":"2023","unstructured":"Kim JH, Oh C-M, Yoo JH. Obesity and novel management of inflammatory bowel disease. World J Gastroenterol. 2023;29:1779\u20131794.","journal-title":"World J Gastroenterol."},{"key":"8597_CR52","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s40259-022-00522-0","volume":"36","author":"M Bassi","year":"2022","unstructured":"Bassi M, Singh S. Impact of obesity on response to biologic therapies in patients with inflammatory bowel diseases. BioDrugs. 2022;36:197\u2013203.","journal-title":"BioDrugs."},{"key":"8597_CR53","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1177\/2050640620954556","volume":"8","author":"T Greuter","year":"2020","unstructured":"Greuter T, Porchet F, Braga-Neto MB et al. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: results from the Swiss inflammatory bowel disease cohort. UEG J. 2020;8:1196\u20131207.","journal-title":"UEG J."},{"key":"8597_CR54","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1007\/s10620-015-3629-5","volume":"60","author":"A Flores","year":"2015","unstructured":"Flores A, Burstein E, Cipher DJ et al. Obesity in inflammatory bowel disease: a marker of less severe disease. Dig Dis Sci. 2015;60:2436\u20132445.https:\/\/doi.org\/10.1007\/s10620-015-3629-5","journal-title":"Dig Dis Sci."},{"key":"8597_CR55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0016-5085(71)80143-9","volume":"60","author":"S Cohen","year":"1971","unstructured":"Cohen S, Kpplan M, Gottlieb L et al. Liver disease and gallstones in regional enteritis. Gastroenterology. 1971;60:237\u2013245.","journal-title":"Gastroenterology."},{"key":"8597_CR56","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","volume":"55","author":"J Satsangi","year":"2006","unstructured":"Satsangi J. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55:749\u2013753.","journal-title":"Gut."},{"key":"8597_CR57","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/gut.2007.140939","volume":"57","author":"L Peyrin-Biroulet","year":"2008","unstructured":"Peyrin-Biroulet L. Is ileocaecal Crohn\u2019s disease L1 or L3 according to the Montreal classification? Gut. 2008;57:427\u2013427.","journal-title":"Gut."},{"key":"8597_CR58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00054725-199805000-00003","volume":"4","author":"A Lapidus","year":"1998","unstructured":"Lapidus A, Einarsson C. Bile composition in patients with ileal resection due to Crohn\u2019s disease. Inflamm Bowel Dis. 1998;4:89\u201394.","journal-title":"Inflamm Bowel Dis."},{"key":"8597_CR59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000159379","volume":"78","author":"A Holzer","year":"2008","unstructured":"Holzer A, Harsch S, Renner O et al. Diminished expression of apical sodium-dependent bile acid transporter in gallstone disease is independent of ileal inflammation. Digestion. 2008;78:52\u201359.","journal-title":"Digestion."},{"key":"8597_CR60","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ibd.21219","volume":"16","author":"U Navaneethan","year":"2010","unstructured":"Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1598\u20131619.","journal-title":"Inflamm Bowel Dis."},{"key":"8597_CR61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0002-9610(83)90175-7","volume":"145","author":"HA Pitt","year":"1983","unstructured":"Pitt HA, King W 3rd, Mann LL et al. Increased risk of cholelithiasis with prolonged total parenteral nutrition. Am J Surg. 1983;145:106\u2013112.","journal-title":"Am J Surg."},{"key":"8597_CR62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/17474124.2019.1574569","volume":"13","author":"T Greuter","year":"2019","unstructured":"Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease\u2014epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol. 2019;13:307\u2013317.","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"8597_CR63","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad061","author":"Y Kilic","year":"2023","unstructured":"Kilic Y, Kamal S, Jaffar F et al. Prevalence of extraintestinal manifestations in inflammatory bowel disease: a systematic review and meta-analysis. Inflamm Bowel Dis. 2023. https:\/\/doi.org\/10.1093\/ibd\/izad061.","journal-title":"Inflamm Bowel Dis."},{"key":"8597_CR64","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.2174\/0929867324666170530080636","volume":"26","author":"A Di Ciaula","year":"2019","unstructured":"Di Ciaula A, Garruti G, Fr\u00fchbeck G et al. The role of diet in the pathogenesis of cholesterol gallstones. Curr Med Chem. 2019;26:3620\u20133638.","journal-title":"Curr Med Chem."},{"key":"8597_CR65","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.4254\/wjh.v7.i27.2716","volume":"7","author":"R Hirten","year":"2015","unstructured":"Hirten R, Sultan K, Thomas A et al. Hepatic manifestations of non-steroidal inflammatory bowel disease therapy. World J Hepatol. 2015;7:2716\u20132728.","journal-title":"World J Hepatol."},{"key":"8597_CR66","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/0016-5085(83)90204-4","volume":"84","author":"B Messing","year":"1983","unstructured":"Messing B, Bories C, Kunstlinger F, Bernier J-J. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis? Gastroenterology. 1983;84:1012\u20131019.","journal-title":"Gastroenterology."},{"key":"8597_CR67","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.3390\/nu14214480","volume":"14","author":"D Berlana","year":"2022","unstructured":"Berlana D. Parenteral nutrition overview. Nutrients. 2022;14:4480.","journal-title":"Nutrients."},{"key":"8597_CR68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1365-2036.2000.014s2054.x","volume":"14","author":"M Angelico","year":"2000","unstructured":"Angelico M, Guardia PD. Review article: hepatobiliary complications associated with total parenteral nutrition. Aliment Pharmacol Ther. 2000;14:54\u201357.","journal-title":"Aliment Pharmacol Ther."},{"key":"8597_CR69","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-4804(86)90145-9","volume":"40","author":"EL Muller","year":"1986","unstructured":"Muller EL, Grace PA, Pitt HA. The effect of parenteral nutrition on biliary calcium and bilirubin. J Surg Res. 1986;40:55\u201362.","journal-title":"J Surg Res."},{"key":"8597_CR70","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0002-9610(89)90443-1","volume":"157","author":"E Shiloni","year":"1989","unstructured":"Shiloni E, Coronado E, Freund HR. Role of total parenteral nutrition in the treatment of Crohn\u2019s disease. Am J Surg. 1989;157:180\u2013185.","journal-title":"Am J Surg."},{"key":"8597_CR71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/00365521.2013.860557","volume":"49","author":"JK Triantafillidis","year":"2013","unstructured":"Triantafillidis JK, Papalois AE. The role of total parenteral nutrition in inflammatory bowel disease: current aspects. Scand J Gastroenterol. 2013;49:3\u201314.","journal-title":"Scand J Gastroenterol."},{"key":"8597_CR72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/gut.27.Suppl_1.81","volume":"27","author":"C Matuchansky","year":"1986","unstructured":"Matuchansky C. Parenteral nutrition in inflammatory bowel disease. Gut. 1986;27:81\u201384.","journal-title":"Gut."},{"key":"8597_CR73","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jpen.1875","volume":"45","author":"MA Kucharski","year":"2021","unstructured":"Kucharski MA, Wierzbicka A, Tsibulski A et al. Parenteral and enteral nutrition: a bridge to healing and biological therapy in a patient with enterocutaneous fistula and sepsis complicated Crohn\u2019s disease. J Parenter Enteral Nutr. 2021;45:430\u2013433.","journal-title":"J Parenter Enteral Nutr."},{"key":"8597_CR74","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3390\/nu12051244","volume":"12","author":"E Zittan","year":"2020","unstructured":"Zittan E, Gralnek IM, Hatoum OA et al. Preoperative exclusive total parental nutrition is associated with clinical and laboratory remission in severe active Crohn\u2019s disease\u2014a pilot study. Nutrients. 2020;12:1244.","journal-title":"Nutrients."},{"key":"8597_CR75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11845-018-1836-8","volume":"188","author":"A McNeice","year":"2019","unstructured":"McNeice A, Scott R, Rafferty GP et al. The hepatobiliary complications of malnutrition and nutritional support in adults. Ir J Med Sci. 2019;188:109\u2013117.","journal-title":"Ir J Med Sci."},{"key":"8597_CR76","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1001\/archsurg.1996.01430170102020","volume":"131","author":"J Thompson","year":"1996","unstructured":"Thompson J. The role of prophylactic cholecystectomy in the short-bowel syndrome. Arch Surg. 1996;131:556\u2013559.","journal-title":"Arch Surg."},{"key":"8597_CR77","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1007\/s11605-018-3979-3","volume":"23","author":"ND Appleton","year":"2019","unstructured":"Appleton ND, Lal S, Carlson GL et al. Cholelithiasis and related morbidity in chronic intestinal failure: a longitudinal cohort study from a National Specialized Centre. J Gastrointest Surg. 2019;23:2002\u20132006.","journal-title":"J Gastrointest Surg."},{"key":"8597_CR78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1586\/17474124.2016.1109445","volume":"10","author":"P Portincasa","year":"2016","unstructured":"Portincasa P, Di Ciaula A, de Bari O, Garruti G, Palmieri VO, Wang DQ-H. Management of gallstones and its related complications. Expert Rev Gastroenterol Hepatol. 2016;10:93\u2013112.","journal-title":"Expert Rev Gastroenterol Hepatol."},{"key":"8597_CR79","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/jhbp.946","volume":"28","author":"JH Choi","year":"2021","unstructured":"Choi JH, Lee SH, Cho IR, Paik WH, Ryu JK, Kim Y-T. Ursodeoxycholic acid for the prevention of gallstone and subsequent cholecystectomy following gastric surgery: a systematic review and meta-analysis. J Hepatobiliary Pancreat Sci. 2021;28:409\u2013418.","journal-title":"J Hepatobiliary Pancreat Sci."},{"key":"8597_CR80","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bpg.2006.03.008","volume":"20","author":"NG Venneman","year":"2006","unstructured":"Venneman NG, van Erpecum KJ. Gallstone disease: primary and secondary prevention. Best Pract Res Clin Gastroenterol. 2006;20:1063\u20131073.","journal-title":"Best Pract Res Clin Gastroenterol."},{"key":"8597_CR81","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00535-022-01886-4","volume":"57","author":"A Mulliri","year":"2022","unstructured":"Mulliri A, Menahem B, Alves A et al. Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials. J Gastroenterol. 2022;57:529\u2013539.","journal-title":"J Gastroenterol."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08597-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08597-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T13:15:18Z","timestamp":1731676518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08597-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":81,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["8597"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08597-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]},"assertion":[{"value":"8 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}